Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Liat Schwartz-Sagi"'
Autor:
John J. Mitchell, Barbara K. Burton, Michael B. Bober, Philippe M. Campeau, Shelda Cohen, Sara Dosenovic, Carolyn Ellaway, Kaustuv Bhattacharya, Nathalie Guffon, David Hinds, Alice Lail, Shuan-Pei Lin, Martin Magner, Julian Raiman, Liat Schwartz-Sagi, Karolina M. Stepien
Publikováno v:
Molecular Genetics and Metabolism. 137:164-172
The Morquio A Registry Study (MARS) is an ongoing, multinational, observational study of patients with MPS IVA. Key objectives of MARS are to characterize the heterogeneity and natural history of disease and to evaluate long-term effectiveness and sa
Autor:
Clare Sun, Beth Christian, Roger G. Owen, Marshall Baek, Simon Rule, Deborah M. Stephens, John M. Pagel, John C. Byrd, Jeff P. Sharman, Martin J.S. Dyer, Richard R. Furman, Jennifer R. Brown, Michael Wang, Peter Hillmen, Susan O'Brien, Liat Schwartz-Sagi, Paolo Ghia, Wojciech Jurczak, Matthew Streetly, Priti Patel
Publikováno v:
Journal of Clinical Oncology. 38:8064-8064
8064 Background: Acala is a next-generation, highly selective, covalent Bruton tyrosine kinase inhibitor approved in the US for patients (pts) with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and previously treated mantle cell